Clinical Trial Update: Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether piperacillin-tazobactam achieves the pharmacodynamic target in people with obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diseases
• Obesity

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: CR-CSSS Champlain-Charles-Le Moyne | Conditions: Infections, Obesity and Obesity-related Medical Conditions | Phase 4 | Status: COMPLETED